Search

Author/Creator Teuber, Gerlinde

1. 1981. Real-World Data on Safety and Effectiveness of Glecaprevir/Pibrentasvir for the Treatment of Patients With Chronic Hepatitis C Virus Infection on Opioid Substitution Therapy: Latest Results from the German Hepatitis C-Registry. (26th November 2018)

Authors:
Reimer, Jens; Stoehr, Albrecht; Naumann, Uwe; Teuber, Gerlinde; Zamani, Carsten; Mauss, Stefan; Qurishi, Nazifa; Lohmann, Kristina; Kleine, Henning; Pangerl, Andreas; Christensen, Stefan
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S575
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparison of new faecal antigen test with 13C-urea breath test for detecting Helicobacter pylori infection and monitoring eradication treatment: prospective clinical evaluation. Issue 7228 (15th January 2000)

Authors:
Braden, Barbara; Teuber, Gerlinde; Dietrich, Christoph F; Caspary, Wolfgang F; Lembcke, Bernhard
Journal:
BMJ
Issue:
Volume 320:Issue 7228(2000)
Page Start:
148
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R). Issue 1 (January 2022)

Authors:
Stein, Kerstin; Stoehr, Albrecht; Klinker, Hartwig; Teuber, Gerlinde; Naumann, Uwe; John, Christine; Heyne, Renate; Serfert, Yvonne; Niederau, Claus; Zeuzem, Stefan; Berg, Thomas; Wiegand, Johannes
Journal:
European journal of gastroenterology & hepatology
Issue:
Volume 34:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial. (October 2019)

Authors:
Traussnigg, Stefan; Schattenberg, Jörn M; Demir, Münevver; Wiegand, Johannes; Geier, Andreas; Teuber, Gerlinde; Hofmann, Wolf Peter; Kremer, Andreas E; Spreda, Frank; Kluwe, Johannes; Petersen, Jörg; Boettler, Tobias; Rainer, Florian; Halilbasic, Emina; Greinwald, Roland; Pröls, Markus; Manns, Mi...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 4:Number 10(2019)
Page Start:
781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry. Issue 8 (15th March 2019)

Authors:
Berg, Thomas; Naumann, Uwe; Stoehr, Albrecht; Sick, Christoph; John, Christine; Teuber, Gerlinde; Schiffelholz, Willibold; Mauss, Stefan; Lohmann, Kristina; König, Bettina; Pangerl, Andreas; Niederau, Claus
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 49:Issue 8(2019)
Page Start:
1052
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R). Issue 10 (12th August 2021)

Authors:
Hüppe, Dietrich; Stoehr, Albrecht; Buggisch, Peter; Mauss, Stefan; Klinker, Hartwig; Teuber, Gerlinde; Hidde, Dennis; Lohmann, Kristina; Bondin, Mark; Wedemeyer, Heiner
Journal:
Journal of viral hepatitis
Issue:
Volume 28:Issue 10(2021)
Page Start:
1474
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗